<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">BALSALAZIDE</span><br/>(bal-sal'a-zide)<br/><span class="topboxtradename">Colazal<br/></span><b>Classifications:</b> <span class="classification">gastrointestinal agent</span>; <span class="classification">mucous membrane agent</span><br/><b>Prototype: </b>Mesalamine (5-ASA)<br/><b>Pregnancy Category: </b>B<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>750 mg capsules</p>
<h1><a name="action">Actions</a></h1>
<p>A prodrug of mesalamine that remains intact until it reaches the lumen of the colon. Thought to decrease inflammation of the
         mucous lining of the colon by blocking cyclooxygenase and inhibiting prostaglandin synthesis in the lining of the colon.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>An antiinflammatory agent and a prodrug of 5-ASA.</p>
<h1><a name="uses">Uses</a></h1>
<p>Treatment of mild to moderate active ulcerative colitis.</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Prior hypersensitivity to salicylates, balsalazide.</p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>Hypersensitivity to mesalamine, sulfasalazine, olsalazine. Allergic response to any medications; hepatic or renal impairment;
         pregnancy (category B), lactation; pyloric stenosis. Safety and efficacy in children are not established.
      </p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Ulcerative Colitis</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 2250 mg (3 times 750 mg) t.i.d. for 812 wk<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Give in a consistent manner with respect to food intake (i.e., either always with or always without food).</li>
<li>Store at room temperature, preferably between 15°30° C (59°86° F).</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead"> Body as a Whole:</span> Arthralgia, fatigue, fever, pain, back pain. <span class="typehead">CNS:</span> Headache, insomnia. <span class="typehead">GI:</span> Abdominal pain, nausea, diarrhea, vomiting, rectal bleeding, flatulence, dyspepsia, coughing, anorexia. <span class="typehead">Respiratory:</span> Rhinitis, pharyngitis. 
      <h1><a name="interactions">Interactions</a></h1>No clinically significant interactions established. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Low and variable absorption from the colon. <span class="typehead">Distribution:</span> &gt;99% protein bound. <span class="typehead">Metabolism:</span> Metabolized in colon by bacterial azoreductases to release 5-aminosalicylic acid and 4-aminobenzoyl-beta-alanine. <span class="typehead">Elimination:</span> 25% of metabolites excreted in urine. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Monitor for S&amp;S of myelosuppression in patients also receiving azathioprine.</li>
<li>Lab tests: Closely monitor CBS with concomitant azathioprine therapy; monitor renal and liver functions when used with other
            aminosalicylates.
         </li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Report worsening of S&amp;S of colitis to physician (e.g., diarrhea, abdominal pain, fever, rectal bleeding).</li>
<li>Do not breast feed while taking this drug without consulting physician.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>